Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JCAP
4301
DELISTED
Jernigan Capital, Inc.
JCAP
| $191K | ﹤0.01% |
+8,300
| New | +$180K |
|
|
CYBR
4302
DELISTED
CyberArk
CYBR
| $190K | ﹤0.01% |
3,734
-37,648
| -91% | -$1.92M |
|
4303
Lee Enterprises
LEE
$175M
| $190K | ﹤0.01% |
7,311
+3,671
| +101% | +$104K |
|
4304
CALL
Teradata
TDC
$3.24B
| $190K | ﹤0.01% |
6,100
-18,300
| -75% | -$553K |
|
4305
PUT
Urban Outfitters
URBN
$6.65B
| $190K | ﹤0.01% |
8,000
-60,600
| -88% | -$1.57M |
|
|
BNFT
4306
DELISTED
Benefitfocus, Inc.
BNFT
| $190K | ﹤0.01% |
6,821
+2,380
| +54% | +$68.2K |
|
4307
Atara Biotherapeutics
ATRA
$77M
| $189K | ﹤0.01% |
367
+20
| +6% | +$8.28K |
|
|
FARM
4308
DELISTED
Farmer Brothers
FARM
| $189K | ﹤0.01% |
5,363
-5,455
| -50% | -$183K |
|
4309
CALL
PJT Partners
PJT
$4.36B
| $189K | ﹤0.01% |
+5,400
| New | +$187K |
|
|
CONN
4310
PUT
DELISTED
Conn's Inc.
CONN
| $189K | ﹤0.01% |
21,600
+18,900
| +700% | +$190K |
|
|
CYBE
4311
DELISTED
Cyberoptics Corp
CYBE
| $189K | ﹤0.01% |
+7,300
| New | +$234K |
|
|
INWK
4312
DELISTED
InnerWorkings, Inc.
INWK
| $189K | ﹤0.01% |
18,949
+4,073
| +27% | +$39.4K |
|
4313
PUT
Sempra
SRE
$57.3B
| $188K | ﹤0.01% |
3,400
-400
| -11% | -$21.2K |
|
4314
St. Joe Company
JOE
$3.64B
| $187K | ﹤0.01% |
10,964
-82,539
| -88% | -$1.41M |
|
4315
Johnson Outdoors
JOUT
$502M
| $187K | ﹤0.01% |
5,122
+5,119
| +170,633% | +$179K |
|
4316
PUT
ScottsMiracle-Gro
SMG
$3.97B
| $187K | ﹤0.01% |
2,000
-600
| -23% | -$55.6K |
|
4317
United Natural Foods
UNFI
$2.87B
| $187K | ﹤0.01% |
4,302
-2,900
| -40% | -$131K |
|
4318
Expro Ltd
XPRO
$1.79B
| $187K | ﹤0.01% |
2,963
+1,832
| +162% | +$129K |
|
|
OIL
4319
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
| $187K | ﹤0.01% |
33,447
-9,200
| -22% | -$54.3K |
|
4320
iShares Agency Bond ETF
AGZ
$564M
| $186K | ﹤0.01% |
+1,644
| New | +$185K |
|
4321
CALL
Burlington
BURL
$23.2B
| $185K | ﹤0.01% |
1,900
-700
| -27% | -$62K |
|
4322
CONMED
CNMD
$1.55B
| $185K | ﹤0.01% |
4,163
+1,895
| +84% | +$81.5K |
|
4323
PUT
Comstock Resources
CRK
$3.94B
| $185K | ﹤0.01% |
+20,000
| New | +$202K |
|
4324
CALL
Eldorado Gold
EGO
$8.37B
| $185K | ﹤0.01% |
10,860
-13,800
| -56% | -$231K |
|
4325
Monro
MNRO
$399M
| $185K | ﹤0.01% |
3,549
-4,081
| -53% | -$231K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.